Episode 59
Biotech Hangout
00:00
The Macro Environment in Biotech
We're all waiting for what seems like a growing, maturing crop of private companies to make their way into the public markets and one form or another. You can't claim the IPO window is open because one very well-positioned company gets through successfully. But every little bit helps. And I think the broader macro environment, hopefully, will remain favorable.
Transcript
Play full episode
